Read the third and final installment of our debate, which looks ahead at future research trends and the potential for personalized medicine.
Read the second installment of our Alzheimer’s genetics debate, with this part focusing on current research priorities, challenges and ethical concerns.
In the first installment of this debate, our experts discuss the contribution of genetics to Alzheimer’s risk, the differences between early- and late-onset disease, and how new technologies have advanced our understanding of this ever-expanding field.
Rachelle Doody, Global Head of Neurodegeneration at Roche, discusses her personal interest in Alzheimer’s and Roche’s current research pipeline.
Ram tells Lauren Pulling about his research into the relationship between Alzheimer’s pathology and sleep spindles, shared recently at AAIC.
Join researchers, clinicians, charities and our own NC team on our #VoicesForAlzheimers campaign for World Alzheimer’s Month, as we try to defeat dementia!
Luciano Rossetti discusses the recent European Commission cladribine approval, as well as the current outlook for the multiple sclerosis drug pipeline.
Watch a live debate filmed at Frontiers in TBI (London, UK), featuring speakers David Sharp and Lee Goldstein.
David Brody discusses his work on animal models of neurodegeneration following TBI, as well as new research into astrocyte degeneration in CTE.
Lee Goldstein discusses his work on human pathology and animal models of chronic traumatic encephalopathy, and where he thinks the brain injury field could be in 5 years’ time.